• Info
  • Insider Ownership

Insider Trading & Ownership of Terry-Ann Burrell

Location
Cambridge, MA
Summary
The estimated net worth of Terry-Ann Burrell is at least $3,647,956 dollars as of 03 Jul 2024. Terry-Ann Burrell is the Chief Financial Officer of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $3.13M. Terry-Ann Burrell is the Director of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $514.1K.
Signature
/s/ Jonathan Golightly, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Terry-Ann Burrell and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Terry-Ann Burrell has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,647,956.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Beam Therapeutics Inc. ($3,133,858).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Terry-Ann Burrell

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BEAM Beam Therapeutics Inc. Chief Financial Officer $3,133,858 26 Apr 2024
RXRX RECURSION PHARMACEUTICALS, INC. Director $514,098 01 Jul 2024
RAPP Rapport Therapeutics, Inc. Director 06 Jun 2024

Insider Transactions Reported by Terry-Ann Burrell:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.